Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-neegative chronic hepatitis B: A multicentre cohort study
Milan J. Sonneveld*, Shao Ming Chiu, the CREATE study group, Jun Yong Park, Sylvia M. Brakenhoff, Apichat Kaewdech, Wai Kay Seto, Yasuhito Tanaka, Ivana Carey, Margarita Papatheodoridi, Piero Colombatto, Florian van Bömmel, Thomas Berg, Fabien Zoulim, Sang Hoon Ahn, George N. Dalekos, Nicole S. Erler, Maurizia Brunetto, Heiner Wedemeyer, Markus CornbergMan Fung Yuen, Kosh Agarwal, Andre Boonstra, Maria Buti, Teerha Piratvisuth, George Papatheodoridis, Chien Hung Chen, Benjamin Maasoumy
Research output: Contribution to journal › Article › Academic › peer-review
7Citations
(Scopus)
38Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-neegative chronic hepatitis B: A multicentre cohort study'. Together they form a unique fingerprint.